In VivoQubit Pharmaceuticals, a biotech that employs quantum physics and artificial intelligence for drug discovery, and Sorbonne University have launched a quantum AI model that could reduce drug synthesis
ScripAbbVie is taking a deep dive into CAR-T therapies for autoimmune diseases with its acquisition of privately owned Capstan Therapeutics for up to $2.1bn, an investment that both bolsters its autoimmune
ScripBayer’s bid to maintain its lead in the anti-vascular endothelial growth factor (VEGF) eye disease space has received a boost with a fresh approval in Europe that extends the intervals between injecti
ScripPfizer stands to expand the addressable market for its hemophilia A and B drug Hympavzi (marstacimab-hncq) with Phase III data showing it is effective in patients with clotting factor inhibitors along